Pulmonary
Samer Abu-Sultaneh, MD, FCCM
Riley Hospital For Children at Indiana University Health
Andrew Miller, MS, RRT, FCCM
Duke University Medical Center
In the United States, one out of 14 children (< age 18) has asthma, leading to about 750,000 emergency department (ED) visits and 74,000 hospital admissions and costing nearly $6 billion yearly. If initial therapy for a severe exacerbation fails, physicians are left with an array of pharmaceutical and respiratory options with limited evidence-based guidance, leading to high practice variability. The lack of clear standards for escalating asthma therapies complicates already challenging scenarios. The respiratory distress of severe asthma exacerbations often precludes methodical decision-making. Multiple guidelines include those developed by the National Asthma Education and Prevention Program and Global Initiative for Asthma, which focus on ED management, with limited guidance for hospitalized children with severe asthma exacerbation; clinicians must derive best practices from institutional protocols and narrative reviews. Evidence-based guidelines for pediatric critical asthma are needed. Speakers will discuss the American Association for Respiratory Care/Pediatric Acute Lung Injury and Sepsis Investigators pediatric critical asthma guidelines; a definition of pediatric critical asthma; and guidance for pharmacologic, respiratory, and systems management.
Ben White, MD – University of Utah Health
Sana J. Said, PharmD – Comer Children's Hospital
Christopher L. Carroll, MD, MS, FCCM (he/him/his) – University of Florida College of Medicine
Danielle Maue, MD (she/her/hers) – Cincinnati Childrens Hospital Medical Center